Abstract
ABSTRACT: Dengue virus is mosquito-borne virus that manifests itself in human infections with dengue fever (DF) to dengue hemorrhagic fever (DHF). DHF can lead to development of dengue shock syndrome (DSS). RNAi works by silencing the target gene expression using siRNA. Hence there arises an urgent need to design potential siRNA against the target sequence of dengue virus gene to control its replication and pathogenicity. This study is aimed to predict self-potential designed siRNA-based therapeutics that might be used for the treatment of dengue virus infection. The prediction of potential siRNA was done by using various computational tools as searching target sequences, multiple sequences alignment, secondary structure prediction, siRNA-target sequence interaction prediction and finally the evaluation of effectiveness of predicted siRNA. Ten pair of potential siRNAs were predicted and designed rationally for silencing five target genes (Capsid, CprM, NS1, NS3 and NS5) of dengue virus used in the study through RNAi technology. The outcomes of this study are ten pair of potential siRNA molecules which might be used as a potential antiviral RNA based therapeutics to suppress the dengue virus replication.
References
Maria GG, Scott BH, Harvey A, Philippe B, Jeremy F. Dengue: a continuing global threat. Nat Rev Microbiol. 2010; 8(12 0): S7-16.
Gubler DJ. Dengue and Dengue Hemorrhagic Fever. Clin Microbiol Rev. 1998; 11(3):480-496.
Erik A. Henchal J. Robert P. The Dengue Viruses. Clin Microbiol rev. 1990; 376-396.
Obbard DJ, Gordon KHJ, Buck AH, Francis MJ. The evolution of RNAi as a defence against viruses and transposable elements. Philos Trans R Soc Lond B Biol Sci. 2009; 364(1513): 99-115.
Ronald HM, Plasterk A. Dicers at RISC: The Mechanism of RNAi. Cell. 2004; 117:1.
Traci M. Hall T. Structure and Function of Argonaute Proteins. Structure. 2005; 13:10.
Gaglione M, Mercurio ME, Potenza N, Mosca N, Russo A. Synthesis and Gene Silencing Properties of siRNAs Containing Terminal Amide Linkages. Biomed Res Int. 2014; 9016-17.
Joseph AG, Berger AK, and Walton SP. Impact of target mRNA structure on siRNA silencing efficiency: a large-scale study. Biotechnol Bioeng. 2008; 100(4): 744-755.
Kumiko Ui-Te. Optimal choice of functional and off-target effect-reduced siRNAs for RNAi therapeutics. Front Genet. 2013; 4:107.
Ulrike MC, Hakim T, Stephan HB. Thermodynamics of RNA-RNA binding. Structural bioinformatics. 2006; 22:10.
How to cite this article:
Om Prakash, Jain B and Jain A. Designing of putative siRNA to inhibit dengue virus replication. Int. J. Res. Dev. Pharm. L. Sci. 2018; 7(5): 3115-3118. doi: 10.13040/IJRDPL.2278-0238.7(5).3115-3118
This Journal is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright (c) 2020 Array